Skip to content
TrialScanner

NCT04365868

Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis

Phase 2/Phase 3TerminatedGALTLead

Registry record

Lead sponsor
Galectin Therapeutics Inc.
Conditions
Prevention of Esophageal Varices; NASH - Nonalcoholic Steatohepatitis; Cirrhosis
Primary completion
Mar 11, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04365868 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04365868: Study Evaluating the... | TrialScanner